Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7

In brief

This randomized phase II trial studies how well electroacupuncture therapy works in reducing chronic pain in patients following surgery for stage I-III breast cancer. Electroacupuncture therapy is a type of complementary integrative medicine in which pulses of weak electrical current are sent through very thin, solid, sterile, stainless steel needles into certain points in the skin. Electroacupuncture therapy may help to lower pain and other surgery-related symptoms.

Key facts

Study ID

NCT02754752

Run by

M.D. Anderson Cancer Center

People needed

111

Starts

2016-09-13

Expected to finish

2026-12-31

Last updated by the study team

2026-04-15

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Be adult women >/= 18 years of age.
• Be able to read, write, and speak English
• Able to give informed consent
• Have a history of stage I, II, or III breast cancer
• Have a documented visit with an oncologist during the previous 12-months
• Have no current evidence of disease
• Have persistent pain (unrelated to aromatase inhibitors or chemotherapy-induced peripheral neuropathy) for at least 3 months following treatment for breast cancer
• Have pain severity (arithmetic mean of four pain severity items) >= 2 on Brief Pain Inventory (BPI)
• Have worst pain >= to 4 (0-10 numeric rating scale [NRS]) in the preceding week
• Be willing and able to adhere to all study-related procedures
• Have completed all cancer treatment (including surgery, chemotherapy and/or radiation) at least 4 months prior to enrollment
• Have documented lab work with absolute neutrophil count (ANC) >= 1.0 K/uL and platelets >= 50 K/uL in the past 12 months
• If applicable, maintain self-management of lymphedema symptoms being performed at home at time of study entry

You may not qualify if…

• Metastatic breast cancer (stage IV)
• Known bleeding disorder per patient reported history
• Cardiac pacemaker or other implanted electronic devices
• New or planned new lymphedema treatment during the study period
• Currently receiving or ever received acupuncture for present pain condition
• Received acupuncture with electrical stimulation for any condition
• Received acupuncture for any condition in the past year

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.